61 studies found for:    "Berger disease"
Show Display Options
Rank Status Study
1 Completed Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis, IGA;   Nephropathy, IGA;   IGA Nephropathy
Interventions: Drug: ACE inhibitor + statin;   Drug: Sirolimus (study drug)+ACE inhibitor + statin
2 Completed A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
3 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
4 Completed Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: ENALAPRIL VALSARTAN METHYLPREDNISONE
5 Completed
Has Results
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: allopurinol;   Other: continue their usual therapy
6 Completed A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
Condition: IgA Nephropathy
Intervention:
7 Not yet recruiting Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Losartan;   Drug: Abelmoschus manihot
8 Recruiting Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
Condition: IgA Nephropathy
Interventions: Drug: irbesartan;   Drug: methylprednisolone (MP) or prednisone (pred);   Drug: mycophenolate mofetil (MMF)
9 Completed An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
Condition: IgA Nephropathy
Intervention:
10 Terminated Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Conditions: IGA Nephropathy;   Proteinuria
Intervention: Biological: OPL-CCL2-LPM
11 Recruiting Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: prednisone plus cyclophosphamide;   Drug: Prednisone alone
12 Completed Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Mycophenolate mofetil
13 Completed Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Procedure: gene transcription and cytometry
14 Recruiting BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
Condition: IgA Nephropathy
Interventions: Drug: Blisibimod;   Drug: Placebo
15 Not yet recruiting BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Blisibimod;   Drug: Placebo
16 Recruiting Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Study)
Condition: IgA Glomerulonephritis
Interventions: Drug: methylprednisolone;   Drug: Placebo,
17 Active, not recruiting The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
Condition: Primary IgA Nephropathy
Interventions: Drug: NEFECON;   Other: Placebo
18 Recruiting IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
Condition: IgA Nephropathy
Intervention: Other: blood test
19 Recruiting Rituximab in Progressive IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Intravenous Rituximab;   Drug: ACE/ARB
20 Completed Mycophenolate Mofetil for IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: mycophenolate mofetil;   Drug: angiotensin blockade

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years